Shanghai Issues Legal Guidebook for Innovative Drug Marketing

Shanghai Issues Legal Guidebook for Innovative Drug Marketing

The Shanghai Municipal Market Supervision Administration Bureau has delivered a legal guidebook tailored for innovative drug marketing to pharmaceutical companies. The guidebook provides recommendations on commercial promotion, academic exchanges, transparent pricing, distributor management, and risk prevention.

Key Provisions

  • Academic Promotion: Companies can conduct academic activities based on their needs, with clear boundaries between academic and promotional behaviors. Inviting doctors for academic activities must comply with laws, regulations, and industry standards.
  • Event Approval: Strengthen the approval process for academic promotion activities before, during, and after events, ensuring authenticity, rationality, and necessity.

Background
The guidebook was developed following a July 2024 research visit by the market supervision administration, which identified marketing plans and potential issues for semaglutide, a glucagon-like peptide-1 (GLP-1) analogue for long-term weight management. The document outlines compliance requirements and was created after consultations with experts and lawyers.-Fineline Info & Tech

Leave a Reply

Your email address will not be published. Required fields are marked *

Insight, China's Pharmaceutical Industry